NEW YORK (GenomeWeb) – Molecular diagnostics developer Curetis announced today it has acquired the real-time qPCR-based Gyronimo platform from joint owners Carpegen and Systec.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.